Hollow-fiber filter IMMUSORBA™

plasmafor plasma therapypolypropylene

Autoimmune diseases (e.g., Systemic lupus erythematosus, Malignant rheumatoid arthritis, Guillain-Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Multiple sclerosis) Features of IMMUSORBA PH-350 (L) Therapeutic plasmapheresis by removing pathogenic substances from patient's plasma by selective adsorption. No need for the replacement of plasma, minimizing the risk of infection with hepatitis, AIDS, etc. Applicable to patients with protein allergy. Caution For patients undergoing treatment with angiotensin-converting enzyme (ACE) inhibitor, there is a possibility that treatment with the IMMUSORBA PH-350 will lead to a drop in blood pressure. Simultaneous treatment with ACE inhibitor and the IMMUSORBA PH-350 must be avoided. The IMMUSORBA PH-350 is intended for the treatment of plasma. Never run whole blood through the IMMUSORBA PH-350. Thrombocytes cannot pass through the IMMUSORBA PH-350 and may cause blockage. Do not use IMMUSORBA PH-350 with plasma containing a large amount of thrombocytes.